Sanofi

Lung
Biotech

Sanofi suspends chronic lung disease phase 2 study

The trial, which began only back in April, was officially reported as halted on July 29, the day before Sanofi's second-quarter earnings report.
Marissa Russo Aug 5, 2026 2:50pm
Belen Garijo Sanofi Merck KGaA

Sanofi CEO ‘looking deeply’ at pipeline as clearout continues

Jul 30, 2026 3:27am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Biogen R&D vet gets in Formation—Chutes & Ladders

Jul 24, 2026 8:30am
Sanofi

Sanofi won't seek approval for eczema drug from Kymab buyout

Jul 24, 2026 5:13am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

EMD Serono taps in new commercial strategy head—Chutes & Ladders

Jun 26, 2026 8:30am
Sanofi headquarters Sanofi

Sanofi, Pangaea in pact to detect underdiagnosed genetic disease

Jun 22, 2026 9:00am